Alex Zhavoronkov, founder and CEO of Insilico Medicine, a clinical stage biotech company powered by generative AI. Photo: Insilico Medicine
Alex Zhavoronkov, founder and CEO of Insilico Medicine, a clinical stage biotech company powered by generative AI. Photo: Insilico Medicine
AI-generated drugs can lead new era in fight against disease, biotech chief says
It is hoped that life-saving drugs will be more effective and cheaper to produce
